Norway· NO-ID_421B067A-A207-4EAA-83AB-FAB77DC422CF
Javlor
A vinflunin product containing vinflunine, registered in Norway by Pierre Fabre Medicament. The same ATC class is registered in 9 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Vinflunin is registered in 9 of 19 countries.
Countries holding a registration under ATC L01CA05 (vinflunin), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 6 of them publish a price we can compare per daily dose
Vinflunin · ATC L01CA05
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
FEST (Norway)- Active substance
- Vinflunine
- Manufacturer
- Pierre Fabre Medicament
- Country
- Norway (NO)
- ATC code
- L01CA05
- ATC class
- Vinflunin
- Defined daily dose
- 27.43 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 5
2 priced- no_merkevare_idID_421B067A-A207-4EAA-83AB-FAB77DC422CF
- no_varenummer0261141 x 10NOK 12906.5
- no_varenummer0261011 x 2NOK 2610.3
- gtin3573994004295
- gtin3573994004271
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vinflunin in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IcelandJavlorPierre Fabre Médicament*
- PolandJavlorPierre Fabre Medicament
- SwedenJavlor 25 mg/ml Koncentrat till infusionsvätska, lösningPierre Fabre Medicament
- SpainJAVLOR 25 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSIONPierre Fabre Medicament
- United KingdomJavlor 250mg/10ml concentrate for solution for infusion vialsPierre Fabre Ltd
- NetherlandsJavlor 25 mg/ml, Concentraat voor oplossing voor infusiePierre Fabre Medicament
- FranceJAVLOR 25 mg/ml, pour solution à diluer pour perfusionPIERRE FABRE MEDICAMENT
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Javlor
- Liechtenstein · Javlor
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a95869a2-eda1-4f97-9da8-38c25d93373c GET /v1/drugs/a95869a2-eda1-4f97-9da8-38c25d93373c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Konsentrat til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Vinflunin",
"merkevare_id": "ID_421B067A-A207-4EAA-83AB-FAB77DC422CF",
"name_form_strength": "Javlor kons til inf oppl 25 mg/ml",
"prescription_group": "C"
}See everything about vinflunin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.